title: Tropheryma whipplei infection and Whipple's disease.
abstract: Recent advances in medical microbiology, epidemiology, cellular biology, and the availability of an expanded set of diagnostic methods such as histopathology, immunohistochemistry, PCR, and bacterial culture have improved our understanding of the clinical range and natural course of Tropheryma whipplei infection and Whipple's disease. Interdisciplinary and transnational research activities have contributed to the clarification of the pathogenesis of the disorder and have enabled controlled trials of different treatment strategies. We summarise the current knowledge and new findings relating to T whipplei infection and Whipple's disease.
authors: Division of Internal Medicine, Krankenhaus Maria Hilf, Daun, Germany. Electronic address: t.marth@krankenhaus-daun.de.
authors: Thomas
authors: T
authors: Marth
authors: Charité-University Medicine Berlin, Campus Benjamin Franklin, Division of Infectious Diseases, Berlin, Germany.
authors: Verena
authors: V
authors: Moos
authors: University Clinic of Internal Medicine III, Allgemeines Krankenhaus Vienna, Vienna, Austria.
authors: Christian
authors: C
authors: Müller
authors: First Department of Internal Medicine, IRCCS Foundation Policlinico San Matteo, University of Pavia, Pavia, Italy.
authors: Federico
authors: F
authors: Biagi
authors: Charité-University Medicine Berlin, Campus Benjamin Franklin, Division of Infectious Diseases, Berlin, Germany.
authors: Thomas
authors: T
authors: Schneider
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome; D007166:Immunosuppressive Agents / Q000009:adverse effects; D054851:Tropheryma; D008061:Whipple Disease / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents